When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two. The solution is ...

Prospective randomized, open-label, multiple dose Phase 1 clinical trial This study was designed to evaluate the early and extended early bactericidal activity (EBA) of fluoroquinolone antibiotics ...

In a meta-analysis, bactericidal antibiotics failed to show any significant difference in clinical cure rates, mortality, microbiological eradication, and treatment failure or relapse rates compared ...

(a) Schematic diagram of the construction of a φ80 phage capsid containing T1-spanin gene. T1-spanin exhibits toxicity toward synthetic bacterium 594; therefore, its expression was suppressed using a ...